Paracrine signal emanating from stressed cardiomyocytes aggravates inflammatory microenvironment in diabetic cardiomyopathy
暂无分享,去创建一个
E. Cartwright | Pablo Binder | N. Frey | J. Chernoff | H. Soran | X. Wang | K. Mace | Oliver J. Müller | Craig P. Smith | E. Swanton | A. Ruiz-Velasco | Wei Liu | S. Hille | Qinghui Ou | H. Fachim | N. Kaur | R. Raja | R. Abouleisa | P. Binder | T. Mohamed | G. Howell | O. Müller | Jessica M. Miller
[1] K. Tracey,et al. Post-Translational Modification of HMGB1 Disulfide Bonds in Stimulating and Inhibiting Inflammation , 2021, Cells.
[2] André F. Rendeiro,et al. Hyperglycemia Induces Trained Immunity in Macrophages and Their Precursors and Promotes Atherosclerosis , 2021, Circulation.
[3] B. Joddar,et al. Cardioprotective Effect of Glycyrrhizin on Myocardial Remodeling in Diabetic Rats , 2021, Biomolecules.
[4] Juhong Yang,et al. Vildagliptin Attenuates Myocardial Dysfunction and Restores Autophagy via miR-21/SPRY1/ERK in Diabetic Mice Heart , 2021, Frontiers in Pharmacology.
[5] Kristin M. French,et al. Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction , 2021, Nature Communications.
[6] Jun Ren,et al. Endoplasmic reticulum stress and unfolded protein response in cardiovascular diseases , 2021, Nature Reviews Cardiology.
[7] T. Madhusudhan,et al. The MEK inhibitor U0126 ameliorates diabetic cardiomyopathy by restricting XBP1's phosphorylation dependent SUMOylation , 2021, International journal of biological sciences.
[8] A. Tomilin,et al. Functional Diversity of Non-Histone Chromosomal Protein HmgB1 , 2020, International journal of molecular sciences.
[9] J. Ge,et al. Cardiomyocyte-restricted high-mobility group box 1 (HMGB1) deletion leads to small heart and glycolipid metabolic disorder through GR/PGC-1α signalling , 2020, Cell death discovery.
[10] Sandeep R. Das,et al. 2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee. , 2020, Journal of the American College of Cardiology.
[11] Aleksandra Stojanovic,et al. Dipeptidyl peptidase-4 inhibitors as new tools for cardioprotection , 2020, Heart Failure Reviews.
[12] Young Hun Kim,et al. Immunological Significance of HMGB1 Post-Translational Modification and Redox Biology , 2020, Frontiers in Immunology.
[13] E. Cartwright,et al. Targeting mir128-3p alleviates myocardial insulin resistance and prevents ischemia-induced heart failure , 2020, eLife.
[14] L. Cai,et al. Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence , 2020, Nature Reviews Cardiology.
[15] D. Grimm,et al. Bioactive Candy: Effects of Licorice on the Cardiovascular System , 2019, Foods.
[16] Steven P Jones,et al. A Physiological Biomimetic Culture System for Pig and Human Heart Slices. , 2019, Circulation research.
[17] J. Ge,et al. HMGB1 enhances mechanical stress-induced cardiomyocyte hypertrophy in vitro via the RAGE/ERK1/2 signaling pathway , 2019, International journal of molecular medicine.
[18] Kavita Sharma,et al. Nitrosative stress drives heart failure with preserved ejection fraction , 2019, Nature.
[19] Yanyan Qi,et al. Vildagliptin inhibits high free fatty acid (FFA)-induced NLRP3 inflammasome activation in endothelial cells , 2019, Artificial cells, nanomedicine, and biotechnology.
[20] E. Cartwright,et al. Pak2 as a Novel Therapeutic Target for Cardioprotective Endoplasmic Reticulum Stress Response , 2019, Circulation research.
[21] D. Tilley,et al. The Role of Leukocytes in Diabetic Cardiomyopathy , 2018, Front. Physiol..
[22] X. Palomer,et al. Emerging Actors in Diabetic Cardiomyopathy: Heartbreaker Biomarkers or Therapeutic Targets? , 2018, Trends in pharmacological sciences.
[23] S. Kheirouri,et al. Changes of Insulin Resistance and Adipokines Following Supplementation with Glycyrrhiza Glabra L. Extract in Combination with a Low-Calorie Diet in Overweight and Obese Subjects: a Randomized Double Blind Clinical Trial , 2018, Advanced pharmaceutical bulletin.
[24] M. Lindsey,et al. Cardiac macrophage biology in the steady-state heart, the aging heart, and following myocardial infarction , 2017, Translational research : the journal of laboratory and clinical medicine.
[25] L. Nedosugova,et al. Proinflammatory monocyte polarization in type 2 diabetes mellitus and coronary heart disease , 2017 .
[26] S. Paczesny,et al. Editorial: Danger Signals Triggering Immune Response and Inflammation , 2017, Front. Immunol..
[27] M. Volpe,et al. An overview of the inflammatory signalling mechanisms in the myocardium underlying the development of diabetic cardiomyopathy. , 2017, Cardiovascular research.
[28] Toru Suzuki,et al. ER Stress Protein CHOP Mediates Insulin Resistance by Modulating Adipose Tissue Macrophage Polarity. , 2017, Cell reports.
[29] N. Angadi,et al. Effect of dipeptidyl peptidase 4 inhibitors on acute and subacute models of inflammation in male Wistar rats: An experimental study , 2017, International journal of applied & basic medical research.
[30] Y. Huang,et al. Endoplasmic reticulum stress-induced neuronal inflammatory response and apoptosis likely plays a key role in the development of diabetic encephalopathy , 2016, Oncotarget.
[31] S. Palaniyandi,et al. Modulation of Macrophage Polarization and HMGB1-TLR2/TLR4 Cascade Plays a Crucial Role for Cardiac Remodeling in Senescence-Accelerated Prone Mice , 2016, PloS one.
[32] J. Ge,et al. Extracellular high‐mobility group box 1 mediates pressure overload‐induced cardiac hypertrophy and heart failure , 2015, Journal of cellular and molecular medicine.
[33] M. Andrassy,et al. Critical role of RAGE and HMGB1 in inflammatory heart disease , 2015, Proceedings of the National Academy of Sciences.
[34] N. Câmara,et al. Macrophages During the Fibrotic Process: M2 as Friend and Foe , 2015, Front. Immunol..
[35] K. Hoeflich,et al. p21-Activated Kinase 2 Regulates Endothelial Development and Function through the Bmk1/Erk5 Pathway , 2015, Molecular and Cellular Biology.
[36] X. Xiang,et al. Chop deficiency prevents UUO-induced renal fibrosis by attenuating fibrotic signals originated from Hmgb1/TLR4/NFκB/IL-1β signaling , 2015, Cell Death and Disease.
[37] Ryan A Frieler,et al. Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. , 2015, Circulation.
[38] Spiros Denaxas,et al. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people , 2015, The Lancet.
[39] Jun Ren,et al. Endoplasmic reticulum stress and protein quality control in diabetic cardiomyopathy. , 2015, Biochimica et biophysica acta.
[40] Heshui Wu,et al. PARP-1 Mediates LPS-Induced HMGB1 Release by Macrophages through Regulation of HMGB1 Acetylation , 2014, The Journal of Immunology.
[41] Renu Malhotra,et al. IHC Profiler: An Open Source Plugin for the Quantitative Evaluation and Automated Scoring of Immunohistochemistry Images of Human Tissue Samples , 2014, PloS one.
[42] K. Tracey,et al. JAK/STAT1 signaling promotes HMGB1 hyperacetylation and nuclear translocation , 2014, Proceedings of the National Academy of Sciences.
[43] Yawei Xu,et al. Increased serum HMGB1 related with HbA1c in coronary artery disease with type 2 diabetes mellitus. , 2013, International journal of cardiology.
[44] M. Nagata,et al. The hyperglycemia stimulated myocardial endoplasmic reticulum (ER) stress contributes to diabetic cardiomyopathy in the transgenic non-obese type 2 diabetic rats: a differential role of unfolded protein response (UPR) signaling proteins. , 2013, The international journal of biochemistry & cell biology.
[45] Shirin Doroudgar,et al. New concepts of endoplasmic reticulum function in the heart: programmed to conserve. , 2013, Journal of molecular and cellular cardiology.
[46] L. Wold,et al. Metabolic dysfunction in diabetic cardiomyopathy , 2013, Heart Failure Reviews.
[47] P. Vandenabeele,et al. ER stress-induced inflammation: does it aid or impede disease progression? , 2012, Trends in molecular medicine.
[48] Y. Kido,et al. DPP4 inhibitor vildagliptin preserves b -cell mass through amelioration of endoplasmic reticulum stress in C/EBPB transgenic mice , 2012 .
[49] H. Nishitoh. CHOP is a multifunctional transcription factor in the ER stress response. , 2012, Journal of biochemistry.
[50] 舟山 哲. Cardiac nuclear high mobility group box 1 prevents the development of cardiac hypertrophy and heart failure , 2012 .
[51] L. Velloso,et al. Endoplasmic reticulum stress, obesity and diabetes. , 2012, Trends in molecular medicine.
[52] Y. Oike,et al. C/EBP Homologous Protein Deficiency Attenuates Myocardial Reperfusion Injury by Inhibiting Myocardial Apoptosis and Inflammation , 2011, Arteriosclerosis, thrombosis, and vascular biology.
[53] A. Chakraborti,et al. Ameliorative effects of glycyrrhizin on streptozotocin‐induced diabetes in rats , 2011, The Journal of pharmacy and pharmacology.
[54] I. Komuro,et al. Endoplasmic reticulum stress as a therapeutic target in cardiovascular disease. , 2010, Circulation research.
[55] Sarah Hummasti,et al. Endoplasmic Reticulum Stress and Inflammation in Obesity and Diabetes , 2010, Circulation research.
[56] M. Andrassy,et al. HMGB1: the missing link between diabetes mellitus and heart failure , 2010, Basic Research in Cardiology.
[57] I. Komuro,et al. Ablation of C/EBP Homologous Protein Attenuates Endoplasmic Reticulum–Mediated Apoptosis and Cardiac Dysfunction Induced by Pressure Overload , 2010, Circulation.
[58] Randal J. Kaufman,et al. From endoplasmic-reticulum stress to the inflammatory response , 2008, Nature.
[59] Aiqing He,et al. The Unfolded Protein Response Is an Important Regulator of Inflammatory Genes in Endothelial Cells , 2006, Arteriosclerosis, thrombosis, and vascular biology.
[60] L. Wold,et al. Oxidative stress and stress signaling: menace of diabetic cardiomyopathy , 2005, Acta Pharmacologica Sinica.
[61] M. Hori,et al. Prolonged Endoplasmic Reticulum Stress in Hypertrophic and Failing Heart After Aortic Constriction: Possible Contribution of Endoplasmic Reticulum Stress to Cardiac Myocyte Apoptosis , 2004, Circulation.
[62] D. Bell,et al. Diabetic cardiomyopathy. , 2003, Diabetes care.
[63] K. Saksela,et al. Cdc42/Rac1-Mediated Activation Primes PAK2 for Superactivation by Tyrosine Phosphorylation , 2002, Molecular and Cellular Biology.
[64] Thomas D. Schmittgen,et al. Real-Time Quantitative PCR , 2002 .